Keyword: GlaxoSmithKline (GSK)

News

The European Pharmaceuticals Economy at Halftime 2012

25.09.2012 - A Pill a Day - Unlike chemicals, the pharmaceuticals sector does not have cycles. Even in a sluggish economy, sick people will still need medicine. But the widening European debt...

Plant Construction & Process Technology

Thriving Generics

25.09.2012 - Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...

News

Hovione Appoints Mike Ironside as General Manager TTC

31.08.2012 - Hovione announced the appointment of Dr. Mike Ironside as General Manager, TTC in New Jersey. Dr. Ironside was previously with GSK in the UK and with AMRI and most recently with...

News

GlaxoSmithKline Sells Australian Drugs to Aspen for $270 Million

15.08.2012 - GlaxoSmithKline advanced its clear-out of non-core drugs on Wednesday with a deal to sell 25 older brands marketed in Australia to South Africa's Aspen Pharmacare for 172 million...

News

Biotech M&A at 4-Year High as Pharma Faces Expiring Patents

03.08.2012 - Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...

News

EU Crisis Piles on Pain for Europe's Drugmakers

26.07.2012 - Europe's sick economy is infecting its pharmaceuticals sector, traditionally one of the region's most successful industries. Price cuts to rein in healthcare spending reached...

News

Sick Europe Forces GSK to Cut 2012 Sales Outlook

25.07.2012 - GlaxoSmithKline warned on Wednesday that sales in 2012 would be flat as pressure on drug prices intensifies in Europe, due to government austerity measures aimed at curbing...

News

The Long Way Back

19.07.2012 - Business in Great Britain - Since 2008, the UK chemical industry has gone through one of the biggest downturns in production of all the world's leading producers of chemicals. Now...